Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,166 across all filing types
Latest filing 2025-07-24 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Lupin Receives U.S. FDA Approvals for Liraglutide and Glucagon Injectable Products.
Regulatory Filings Classification · 95% confidence The document is a press release announcing the receipt of US FDA approvals for specific pharmaceutical products by Lupin Limited. It is addressed to stock exchanges and regulatory bodies under SEBI Listing Regulations, indicating a disclosure of material information. The content focuses on regulatory approval news rather than financial results, management changes, or detailed financial data. The document length is 5672 characters, which is sufficient for a press release but does not contain financial statements or detailed analysis. It is not an annual or quarterly report, audit report, or earnings release. It is also not a regulatory filing in the sense of compliance documents or certifications, but a corporate announcement of a significant event. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and disclosures that do not fit other specific categories.
2025-07-24 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the receipt of US FDA approvals for specific pharmaceutical products by Lupin Limited. It is addressed to stock exchanges and regulatory bodies under SEBI Listing Regulations, indicating a disclosure of material information. The content focuses on product approvals and business updates rather than financial results, management changes, or regulatory filings. The document is not a financial report, earnings release, or management discussion. It is a corporate announcement about regulatory approval and product launch, which fits best under the category of a general regulatory announcement or compliance disclosure. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (5672 characters) and content confirm it is not a brief report publication announcement or a detailed financial report.
2025-07-24 English
Integrated Report for FY 2024-25 - Revised.
AGM Information Classification · 95% confidence The document is a Notice of the Annual General Meeting (AGM) for Lupin Limited for the financial year 2024-25. It includes details about the AGM date, agenda items such as adoption of audited financial statements, appointment and re-appointment of directors, appointment of auditors, dividend declaration, and adoption of new Articles of Association. The document also references the Integrated Report for FY 2024-25 being enclosed and available on the company's website. The content is typical of an AGM Notice, which is a formal communication sent to shareholders to inform them about the meeting and the business to be transacted. It is not the Annual Report itself, nor a financial statement or earnings release. The document length is substantial but the primary purpose is to notify and provide details for the AGM, including resolutions to be passed. Therefore, the appropriate classification is AGM Information (AGM-R).
2025-07-23 English
Copy of Newspaper Publication relating to Annual General Meeting and e-voting related information.
Interim / Quarterly Report Classification · 95% confidence The document contains a newspaper advertisement relating to the Annual General Meeting (AGM) and e-voting information for Lupin Limited. It mentions the date of the AGM and provides details about the meeting and voting process. Additionally, there is an extract of standalone and consolidated unaudited financial results for the quarter ended June 30, 2025, which includes financial figures such as total income, net profit before and after tax, comprehensive income, paid-up equity share capital, reserves, and earnings per share. The presence of detailed unaudited quarterly financial results indicates this is a financial report for a period shorter than a full fiscal year. The document is not merely an announcement of a report but contains substantive financial data and analysis for the quarter. Therefore, the document should be classified as an Interim / Quarterly Report (IR).
2025-07-22 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document contains a newspaper advertisement relating to the Annual General Meeting (AGM) and e-voting information for Lupin Limited. It mentions the date of the AGM and provides details about the meeting and voting process. The document also includes an extract of unaudited financial results for the quarter ended June 30, 2025, but the primary focus is on the AGM notification and related voting information. The document is not the full annual report or financial report but rather an announcement and advertisement about the AGM and voting. Therefore, it fits the category of AGM Information (AGM-R).
2025-07-22 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-07-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.